Genitourinary infectious disease testing (vaginitis, vaginosis, UTI)
Outpatient policy governing laboratory testing for genitourinary infections including targeted and expanded vaginitis/vaginosis pathogen panels, urine culture for asymptomatic bacteriuria, and molecular/multiplex UTI panels; affects providers ordering these tests for WellCare members.
Added multiple CPT codes to the CPT code table (e.g., 87510, 87660, 87808, 87810, 87850, 0371U, 0372U, 0374U, 0504U, 81515, 87528-87539, 87901, 87903-87904, 87906).
Removed deleted CPT code 0352U from the policy reference table.
Changed policy statements for several criteria sections from 'be considered medically necessary' to 'are considered medically necessary'.
Added 'lab' to the policy title and moved/updated the coding implications and CPT code table.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.